SBRA (Sabra Healthcare REIT, Inc.)

Insider Trading Activity

Every open-market purchase and sale reported by SBRA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
2
code S
Reporting Insiders
17
current holders
SBRA — Recent Form 4 Transactions (latest 2026-09-09)
FiledInsiderRole TypeSharesValue
2026-09-09 RICHARD K MATROS Chair, CEO and President Sell
2026-09-02 Jeffrey A. Malehorn Director A
2026-09-02 JESSICA FLORES Executive VP & CAO A
2026-09-02 Ann Kono Director A
2026-09-02 MICHAEL J FOSTER Director A
2026-09-02 LYNNE S KATZMANN Director A
2026-09-02 Catherine Cusack Director A
2026-09-02 Michael Lourenco Costa Executive VP, CFO & Treasurer A
2026-09-02 Darrin Smith Executive VP, CIO & Secretary A
2026-09-02 Craig A. Barbarosh Director A
2026-09-02 RICHARD K MATROS Chair, CEO and President A
2026-06-18 Catherine Cusack Director A
2026-06-18 LYNNE S KATZMANN Director A
2026-06-18 Jeffrey A. Malehorn Director A
2026-06-18 MICHAEL J FOSTER Director A
2026-06-18 Craig A. Barbarosh Director A
2026-06-18 Ann Kono Director A
2026-06-02 RICHARD K MATROS Chair, CEO and President A
2026-06-02 Michael Lourenco Costa Executive VP, CFO & Treasurer A
2026-06-02 Darrin Smith Executive VP, CIO & Secretary A
2026-06-02 JESSICA FLORES Executive VP & CAO A
2026-06-02 Craig A. Barbarosh Director A
2026-06-02 Catherine Cusack Director A
2026-06-02 MICHAEL J FOSTER Director MIXED
2026-06-02 LYNNE S KATZMANN Director A
2026-06-02 Ann Kono Director A
2026-06-02 Jeffrey A. Malehorn Director A
2026-05-28 MICHAEL J FOSTER Director G
2026-05-27 MICHAEL J FOSTER Director G
2026-03-26 JESSICA FLORES Executive VP & CAO Sell
2026-03-03 RICHARD K MATROS Chair, CEO and President A
2026-03-03 Michael Lourenco Costa Executive VP, CFO & Treasurer A
2026-03-03 Darrin Smith Executive VP, CIO & Secretary A
2026-03-03 JESSICA FLORES Executive VP & CAO A
2026-03-03 Craig A. Barbarosh Director A
2026-03-03 Catherine Cusack Director A
2026-03-03 MICHAEL J FOSTER Director A
2026-03-03 LYNNE S KATZMANN Director A
2026-03-03 Ann Kono Director A
2026-03-03 Jeffrey A. Malehorn Director A
2026-02-12 RICHARD K MATROS Chair, CEO and President A
2026-02-12 Michael Lourenco Costa Executive VP, CFO & Treasurer A
2026-02-12 Darrin Smith Executive VP, CIO & Secretary MIXED
2026-02-12 JESSICA FLORES Executive VP & CAO MIXED
2026-01-12 RICHARD K MATROS Chair, CEO and President MIXED
2026-01-12 Michael Lourenco Costa Executive VP, CFO & Treasurer MIXED
2026-01-12 Darrin Smith Executive VP, CIO & Secretary MIXED
2026-01-12 JESSICA FLORES Executive VP & CAO MIXED
2026-01-05 RICHARD K MATROS Chair, CEO and President A
2026-01-05 Michael Lourenco Costa Executive VP, CFO & Treasurer A
SBRA — Current Insider Holders
InsiderRole Shares HeldValue
Chair, CEO and President 2,613,954
Executive VP, CIO & Treasurer 869,561
Executive VP, CFO & Secretary 474,693
Executive VP, CFO & Treasurer 470,086
Director 338,820
Director 159,033
Director 125,245
Director 117,137
Executive VP, CIO & Secretary 116,919
Director 86,912
Director 83,381
Director 82,847
Executive VP & CAO 72,476
Director 68,977
Director 57,176
Director 51,367
Director 49,548
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the SBRA quote page; the site-wide leaderboard is on the insider transactions hub.